AR012780A1 - Composicion de mesilato de trovafloxacino granulada en seco y composicion de materia que comprende un comprimido de mesilato de trovafloxacino. - Google Patents

Composicion de mesilato de trovafloxacino granulada en seco y composicion de materia que comprende un comprimido de mesilato de trovafloxacino.

Info

Publication number
AR012780A1
AR012780A1 ARP990100191A ARP990100191A AR012780A1 AR 012780 A1 AR012780 A1 AR 012780A1 AR P990100191 A ARP990100191 A AR P990100191A AR P990100191 A ARP990100191 A AR P990100191A AR 012780 A1 AR012780 A1 AR 012780A1
Authority
AR
Argentina
Prior art keywords
trovafloxacino
mesylate
composition
tablet
dry granulated
Prior art date
Application number
ARP990100191A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR012780A1 publication Critical patent/AR012780A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones, especialmente en forma de comprimidos, que contienen la forma poliformo II del mesilato de trovafloxacino, un lubricante, y cleulosamicrocristalina (MC) como diluyente. Tales composiciones que emplean MC como diluyente presentan propiedades de estabilidad durante el almacenamiento y dedisolucion.
ARP990100191A 1998-01-21 1999-01-19 Composicion de mesilato de trovafloxacino granulada en seco y composicion de materia que comprende un comprimido de mesilato de trovafloxacino. AR012780A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
AR012780A1 true AR012780A1 (es) 2000-11-08

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990100191A AR012780A1 (es) 1998-01-21 1999-01-19 Composicion de mesilato de trovafloxacino granulada en seco y composicion de materia que comprende un comprimido de mesilato de trovafloxacino.

Country Status (34)

Country Link
US (1) US6187341B1 (es)
EP (1) EP0930068A3 (es)
JP (1) JPH11269072A (es)
KR (1) KR100314977B1 (es)
CN (1) CN1227743A (es)
AP (1) AP1094A (es)
AR (1) AR012780A1 (es)
AU (1) AU758381B2 (es)
BG (1) BG103106A (es)
BR (1) BR9900116A (es)
CA (1) CA2259698C (es)
CO (1) CO4810225A1 (es)
DZ (1) DZ2712A1 (es)
EA (1) EA003247B1 (es)
GT (1) GT199900004A (es)
HR (1) HRP990023A2 (es)
HU (1) HUP9900154A3 (es)
ID (1) ID23735A (es)
IL (1) IL128051A0 (es)
IS (1) IS4947A (es)
MA (1) MA24747A1 (es)
NO (1) NO990243L (es)
NZ (1) NZ333838A (es)
OA (1) OA10958A (es)
PA (1) PA8466701A1 (es)
PE (1) PE20000169A1 (es)
PL (1) PL330981A1 (es)
SG (1) SG70666A1 (es)
SK (1) SK4299A3 (es)
TN (1) TNSN99007A1 (es)
TR (1) TR199900089A3 (es)
TW (1) TW518224B (es)
YU (1) YU2399A (es)
ZA (1) ZA99393B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU229065B1 (en) * 1998-11-10 2013-07-29 Bayer Ip Gmbh Pharmaceutical moxifloxacin compositions
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
ATE420640T1 (de) * 2001-04-06 2009-01-15 Affinium Pharm Inc Fab-i-inhibitoren
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
US7790709B2 (en) * 2002-12-06 2010-09-07 Affinium Pharmaceuticals, Inc. Heterocyclic compounds, methods of making them and their use in therapy
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
CA2519429C (en) 2003-03-17 2013-08-06 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
ATE382338T1 (de) * 2003-03-19 2008-01-15 Jordanian Pharmaceutical Mfg Nicht-hygroskopische pharmazeutische zusammensetzungen die nicht hydratisierte quinolon-carbonsäure enthalten
US8906413B2 (en) 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
CA2531637A1 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
DK1828167T3 (da) 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
WO2006044805A2 (en) * 2004-10-15 2006-04-27 Supernus Pharmaceuticals, Inc. Less abusable pharmaceutical preparations
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
PT3419628T (pt) 2016-02-26 2021-01-05 Debiopharm Int Sa Medicamento para o tratamento de infeções do pé diabético

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
WO1997007800A1 (en) * 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin

Also Published As

Publication number Publication date
TNSN99007A1 (fr) 2005-11-10
BG103106A (en) 1999-08-31
TW518224B (en) 2003-01-21
NO990243L (no) 1999-07-22
NZ333838A (en) 2000-03-27
AP9901443A0 (en) 1999-03-31
JPH11269072A (ja) 1999-10-05
NO990243D0 (no) 1999-01-20
IS4947A (is) 1999-07-22
BR9900116A (pt) 2000-05-02
EP0930068A2 (en) 1999-07-21
EA199900046A3 (ru) 1999-12-29
KR19990068014A (ko) 1999-08-25
MA24747A1 (fr) 1999-10-01
CO4810225A1 (es) 1999-06-30
DZ2712A1 (fr) 2003-09-01
PE20000169A1 (es) 2000-03-10
HRP990023A2 (en) 1999-08-31
CN1227743A (zh) 1999-09-08
HUP9900154A2 (hu) 1999-09-28
HU9900154D0 (en) 1999-03-29
HUP9900154A3 (en) 2000-12-28
EP0930068A3 (en) 1999-12-22
AP1094A (en) 2002-08-19
TR199900089A2 (xx) 1999-10-21
EA199900046A2 (ru) 1999-08-26
ID23735A (id) 2000-05-11
CA2259698A1 (en) 1999-07-21
PL330981A1 (en) 1999-08-02
YU2399A (sh) 2002-06-19
PA8466701A1 (es) 2000-09-29
KR100314977B1 (ko) 2001-11-24
EA003247B1 (ru) 2003-02-27
IL128051A0 (en) 1999-11-30
AU758381B2 (en) 2003-03-20
AU1217399A (en) 1999-08-12
OA10958A (en) 2001-10-31
CA2259698C (en) 2003-04-15
SK4299A3 (en) 2000-06-12
SG70666A1 (en) 2000-02-22
US6187341B1 (en) 2001-02-13
GT199900004A (es) 2000-07-08
TR199900089A3 (tr) 1999-10-21
ZA99393B (en) 2000-07-21

Similar Documents

Publication Publication Date Title
AR012780A1 (es) Composicion de mesilato de trovafloxacino granulada en seco y composicion de materia que comprende un comprimido de mesilato de trovafloxacino.
TR200102154T2 (tr) Deterjan bileşimleri.
DE69610912D1 (de) Wässrige reinigungszusammensetzungen enthaltend persauerestoffverbindungen und chelatbinder
ES2052337T3 (es) Composicion de detergente en forma de comprimido.
ATE282688T1 (de) Muldentabletten und verfahren zu ihrer herstellung
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
BG106391A (en) Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes
WO2002094020A8 (de) Verwendung von triazolopyrimidin-derivaten als mikrobizide im materialschutz
DE60019084D1 (de) Waschmitteltablette
EP0298666A3 (en) Spray dried ibuprofen compositions
WO2002055601A8 (en) High shrink polyethylene films
AR026209A1 (es) Compuestos monociclicos basicos con accion nk-2 antagonista, procesos de fabricacion y formulas que los contienen
IL156200A0 (en) Thymic epithelial progenitor cells and pharmaceutical compositions containing the same
MX9102021A (es) Composiciones detergentes o blanqueadoras granuladas que contienen blanqueador de midoperoxiacido y perfume.
BR0116205A (pt) 2-piridonas antimicrobianas, suas composições e usos
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
CO4970793A1 (es) Composicion para dispersion molecular con biodisponibilidad aumentada
BG105139A (en) Cyclophosphamide coated tablets
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития
ECSP992822A (es) Comprimido de mesilato de trovafloxacina
NO960151D0 (no) Polyisocyanat-blanding
JPS5668619A (en) Nifedipine-containing solid composition
UY29105A1 (es) Composicion farmacéutica sólida, soluble, formada por una composición farmacéutica activa y una composición farmacéutica polimérica hidrosoluble y procedimiento de prepración
IT8722451A0 (it) Composizione ritardante di fiamma per materiali polimerici in particolare poliolefinici e materiali polimerici autoestinguenti cosi' ottenuti.
AR025767A1 (es) Composiciones de limpieza

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure